<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is the third most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in men and the second most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in women worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Both genetic and epigenetic alterations are common in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and are the driving force of <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:mpath ids='MPATH_270'>adenoma</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence was proposed in the 1980s that described transformation of <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal epithelium to an <z:mpath ids='MPATH_270'>adenoma</z:mpath> and ultimately to an invasive and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic tumor</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Initial genetic changes start in an early <z:mpath ids='MPATH_270'>adenoma</z:mpath> and accumulate as it transforms to <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0008866'>Chromosomal instability</z:mp>, microsatellite instability and CpG island methylator phenotype pathways are responsible for genetic instability in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0008866'>Chromosomal instability</z:mp> pathway consist of activation of proto-oncogenes (KRAS) and inactivation of at least three <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppression genes, namely loss of APC, p53 and loss of heterozogosity (LOH) of long arm of chromosome 18 </plain></SENT>
<SENT sid="6" pm="."><plain>Mutations of TGFBR and PIK3CA genes have also been recently described </plain></SENT>
<SENT sid="7" pm="."><plain>Herein we briefly discuss the basic concepts of genetic integrity and the consequences of defects in the DNA repair relevant to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Epigenetic alterations, essential in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, are also reviewed alongside clinical information relevant to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>